Viewing Study NCT02109393


Ignite Creation Date: 2025-12-25 @ 1:26 AM
Ignite Modification Date: 2026-02-25 @ 4:39 PM
Study NCT ID: NCT02109393
Status: COMPLETED
Last Update Posted: 2016-12-06
First Post: 2014-03-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rehabilitation in Patients With Progressive Supranuclear Palsy
Sponsor: Ospedale Generale Di Zona Moriggia-Pelascini
Organization:

Study Overview

Official Title: Rehabilitation in Patients With Progressive Supranuclear Palsy: Effectiveness of Two Intensive Protocols
Status: COMPLETED
Status Verified Date: 2016-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PSP-MIRTLoko
Brief Summary: The investigators evaluate whether an aerobic, intensive, goal based and multidisciplinary rehabilitation treatment, previously conceived for Parkinson's disease, is effective for patients with progressive supranuclear palsy and whether a driven gait orthosis (Lokomat) can provide further benefits.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
PSP MIRT-Loko 001 OTHER Ospedale Generale di Zona "Moriggia-Pelascini" View